OR WAIT null SECS
December 23, 2014
Protein Sciences will evaluate sourcing Flublok from its Japanese licensee, UMN Pharma, which already runs a large-scale facility for the vaccine.
The partnership will focus on the discovery of antibodies against proteins that are not easily purified in functional form.
December 19, 2014
Merck announced that it acquired OncoEthix, a biotechnology company specializing in oncology drug development, for up to $375 million.
December 18, 2014
Fujifilm Diosynth Biotechnologies announced the completion of the acquisition of Kalon Biotherapeutics, a company that specializes in advanced biologics development manufacturing.
Actavis announced a senior leadership team comprised of both Actavis and Allergan leaders designed to facilitate dynamic company growth.
December 17, 2014
The multi-product biopharmaceutical manufacturing facility is scheduled to start up in 2017.
Biomanufacturing capacity expansion uses modular cleanroom design and single-use technologies.
December 15, 2014
The agency emphasizes the need for robust scientific assessment and more information on safety and efficacy profiles of Ebola therapies in development.
December 14, 2014
Venair Biotech specializes in single-use products for the biotech and pharmaceutical sectors.
December 08, 2014
Under an NIH contract, Paragon Bioservices will design a manufacturing process for recombinant human rhE-selectin protein.